SOCHI, May 15, 2018 – RUSATOM Healthcare, a division of ROSATOM (Russia) and A Brown Company Inc. (Republic of the Philippines) signed a Project Development Agreement on construction of network of irradiation centres in the Philippines.

Roel Z. Castro, President of A Brown Company Inc. (ABCI) and Rustam Rakhmatulin, Deputy Director General of RUSATOM Healthcare, affixed their signatures to the document, which is signed in pursuance of the Memorandum of Understanding and frame work agreement concluded between RUSATOM International Network, a subsidiary of ROSATOM, and ABCI in 2017. The agreement was signed during the 10th International ATOMEXPO forum started on May 14 at The Main Media Centre in Sochi, Russia.

“We welcome with enthusiasm the efforts by private companies like A Brown to put up irradiation facilities that will prolong agricultural produce shelf life. This is a good example of nuclear application for the future development” – Dr.  Carlo Arcilla, Director of PNRI

The aim of the agreement is to further elaborate the Framework Agreement signed on 11 September 2017 and approve the jointly agreed plan of actions of the irradiation centres project in the Philippines.

The pilot project, to be built in the City of Davao, will provide commercial services of product treatment with ionizing radiation. It may also serve as a sterilization platform for medical devices.

“This pilot project that we plan will be the first commercial facility in the Philippines and a major breakthrough which will add value to existing tropical fruits producers looking for export markets, as well as enhancing the quality of high value medical products. We are very privileged to be working closely with Rusatom Healthcare from Russia and with Philippines Nuclear Research Institute (PNRI) in this endeavor” said Roel Castro, President and CEO of ABCI.

The signed document outlines certain stages of the project development, from feasibility studies to construction and commissioning.
“RUSATOM Healthcare offers a turn-key solution in radiation technologies, which will include design and construction of the irradiation centres, equipment manufacturing and delivery, training of personnel and commissioning of the facility. The technology we offer to our Philippine partners is based on more than 70 years of experience in nuclear field, and we hope it will contribute to the sustainable development of the Philippines“, noted Denis Cherednichenko, CEO of RUSATOM Healthcare.

JSC “RUSATOM HEALTHCARE” was established by the subsidiary of the State Corporation “ROSATOM” – the company JSC “ATOMENERGOPROM” for purposes of development and production of equipment and radionuclide products for nuclear medicine and medical radiology, as well as industrial equipment and sterilization solutions for processing different types of products with ionizing radiation on the basis of electron-beam and gamma-ray installations.